Search PubMed⌕ Search

Biomedical subjects

G Herrmann

Publications and source records attributed to G Herrmann.

At least 199 records · Page 11Linked to original sources

Kidney-derived urinary antigens assayed with monoclonal antibodies for the detection of renal damage.

For the quantitation of kidney-derived Urinary Antigens (UA) monoclonal antibodies specific for antigens localized in cells of defined subunits of the nephron were applied in sandwich ELISA. Antigen excretion was measured in the urine of healthy individuals, patients suffering from various diseases, kidney transplant recipients, and healthy volunteers receiving therapeutic doses of antibiotic drugs. In healthy individuals, in patients with diseases primarily affecting the glomerulus, and in inactive phases of chronic diseases antigen excretion was low. Toxic drug effects enhanced antigenuria. Excretion of some or all of the antigens always indicated tubular alterations. The tests thus provide information on location and extent of acute primary tubular damage.

Antibodies, Monoclonal↗

Parathyroid hormone in coronary artery disease--results of a prospective study.

Parathyroid hormone (PTH) influences the calcium metabolism of many different mammalian cell types; indeed, hypertension due to changes in muscle tone is a frequent symptom of hypercalcemic hyperparathyroidism. In a blind study of 81 patients with various forms of heart disease undergoing coronary angiography, the plasma concentrations of the midcarboxyl regional PTH immunoreactivity were determined. PTH concentrations were elevated in 26 of the 56 patients exhibiting organic coronary artery disease (CAD). The plasma PTH levels were highest in those patients with CAD affecting three vessels and in patients with evidence of myocardial infarction. PTH levels were not influenced by previous drug treatments, and did not correlate to stress hormone levels. We propose that increased PTH levels may be a marker for initiation or potentiation of calcium-dependent changes in vascular smooth muscle behavior inducing coronary functional and anatomic lesions typical of CAD.

Adult↗

Treatment of experimental herpes simplex virus type 1 encephalitis in mice with (E)-5-(2-bromovinyl)- and 5-vinyl-1-beta-D-arabinofuranosyluracil: comparison with bromovinyl-deoxyuridine and acyclovir.

The efficiency of (E)-5-(2-bromovinyl)- and 5-vinyl-1-beta-D-arabinofuranosyluracil (BrVaraU, VaraU) as inhibitors of three herpes simplex virus type 1 (HSV-1) strains was assessed in comparison to (E)-5-(2-bromovinyl)-2'-deoxyuridine (BrVUdR), 9-(2-hydroxyethoxymethyl)guanine (ACV), and trisodium phosphonoformate (Na3PFA) using a plaque assay in human embryonic lung fibroblast (HELF) cell cultures. The following order of decreasing activity was found: BrVaraU greater than VaraU greater than BrVU-dR greater than ACV much greater than Na3PFA. In HELF cell cultures, the selectivity indexes of VaraU and BrVaraU were 10 times higher than those of BrVUdR and ACV. Protection of mice from encephalitis and death due to intracerebral (i.c.) infection with a clinical HSV-1 isolate was nearly complete if mice were treated intraperitoneally (i.p.) with two daily doses of VaraU and BrVaraU (100 or 200 mg/kg per day) over a period of 5 or 10 days. The efficacy was similar to ACV, but, using a treatment schedule of three daily i.p. doses over 10 days, with equimolar amounts of the nucleoside analogs, VaraU and BrVaraU (140 and 180 mg/kg per day) were superior to ACV (130 mg/kg per day) (P less than 0.05).

Acyclovir↗

[Single vessel disease of the anterior interventricular branch as a cause of combined anterior and posterior wall infarct in comparison with 2-vessel disease of the RIVA and RCA].

Only few studies deal with the problem of an isolated stenosis of the left anterior descending coronary artery (LAD) leading to a combined anterior and inferior myocardial infarction in the ECG and VCG. In the present study patients with electrocardiographic signs of anterior and inferior myocardial infarction and either one-vessel disease of the LAD branch (n = 27; group I) or two-vessel disease including the LAD and the right coronary artery (RCA) (n = 29; group II) were investigated. Due to the anterior myocardial infarction present in all patients, unequivocal signs of posterior and posterolateral infarct location were missing in the ECG and VCG. There was a distinct variability with regard to Q-wave duration and amplitude in the inferior leads of the ECG and of the Q/R-relation in the scalar lead Y of the VCG (Frank-leads) in patients with isolated LAD disease when compared to those with combined LAD and RCA disease, but no reliable parameter was found in the ECG and VCG which allowed to allocate patients to one of the two groups. On the other hand, there were significant differences in hemodynamics and left ventricular function between the two groups. Group I patients showed a significantly higher left ventricular ejection fraction (mean 49 +/- 15%) than patients with two-vessel disease (group II) (mean 42 +/- 12%) (p less than 0.05). Left ventricular end-diastolic pressures at rest (13 +/- 7 mm Hg).(ABSTRACT TRUNCATED AT 250 WORDS)

Cardiac Catheterization↗

[Echocardiography detection of reduced left ventricular diastolic posterior wall motion in patients with constrictive pericarditis--incidence and correlation with hemodynamics and clinical course].

In 24 patients with chronic constrictive pericarditis (CP) proven by right and left heart catheterization, the amplitude of diastolic left ventricular posterior wall motion was evaluated by M-mode echocardiography and compared with the results of 14 healthy volunteers. The amplitude was significantly less in CP patients than in normal controls (0.3 mm vs. 4.0 mm, p less than 0.001) and no CP patient showed a higher value than 2 mm whereas none of the normal subjects had an amplitude less than 3 mm. In 11 of 13 CP patients undergoing pericardectomy, an increase in amplitude was observed; in 6 of them the amplitude was within normal limits following surgery. No significant correlation between the degree of heart failure or the level of left ventricular end-diastolic pressure and the reduction of the amplitude could be found. In addition, the level of the amplitude did not allow a clear separation between patients who could be treated medically and those requiring pericardectomy. It can be concluded that the reduction of diastolic left ventricular posterior wall motion is a valuable echocardiographic parameter for the noninvasive diagnosis of CP.

Adult↗

Functional radiographs of the craniocervical region and the cervical spine. A new computer-aided technique.

Disabilities of the articulations of the head and cervical spine can often be detected only by exact measurement of functional radiographs. From two radiographs, one in flexion and one in extension, not only can the total mobility of the head be measured, but also the mobility of the individual articulations can be evaluated by taking exact measurements of the position of each vertebra. A method for semi-automatic measuring of such pairs of radiographs is presented. Edges and structures of the bones that are clearly visible in both radiographs are digitized on a graphics tablet. Then, by computer program, each vertebra of the first radiograph is shifted and rotated until it fits best to the respective vertebra of the second radiograph. Thus, for each articulation, the mobility angle and the location of the mobility axis relative to the adjacent vertebra, can be computed. First experiences with this method are presented.

Adult↗

Anti-herpes simplex virus and cytostatic activity of some new 5-substituted 1-(4-hydroxybutyl)-and 1-(2-hydroxyethoxymethyl) uracil nucleoside analogues.

Two series of 5-substituted acyclic uracil nucleoside analogues (5-X-acyclo-U) were evaluated for their inhibitory effects against three herpes simplex virus type 1 (HSV-1) strains and one type 2 (HSV-2) strain in a plaque inhibition assay on human embryonic lung fibroblast (HELF) cell cultures as well as for their ability to inhibit the proliferation of baby hamster kidney cells in suspension (BHK-S) culture. Acyclovir [9-(2-hydroxyethoxymethyl)guanine; ACV] and (S)-9-(2,3-dihydroxypropyl)adenine [(S)-DHPA] were used as reference compounds. Only two derivatives, 1-(4-hydroxybutyl)-5-(2,2-dibromovinyl)uracil (Br2V-HBU) and 1-(2-hydroxyethoxymethyl)-5-(2,2-dibromovinyl)-uracil (Br2V-HEMU) proved active, but only at high concentrations (57-350 mumol/l) and without selectivity of anti-herpes activity, whereas ACV showed strong inhibition of HSV-1 and HSV-2 and a low cytostatic effect on BHK-S cells (50% inhibitory concentrations are 0.25-0.73, 2.1, and 240 mumol/l for HSV-1, HSV-2, and BHK-S, respectively), demonstrating a high antiherpes selectivity. In contrast, all other 5-X acyclo-U analogues [X = methyl, ethyl, propyl, butyl, vinyl, and 2-bromovinyl; acyclo = 1-(4-hydroxybutyl) and 1-(2-hydroxyethoxymethyl)] as well as the reference compound (S)-DHPA were inactive at concentrations up to 0.5-1 mmol/l. Some structure to activity relationships of acyclic pyrimidine and purine nucleoside analogues are discussed.

Acyclovir↗

[Heart transplantation in cardiomyopathy].

Within the spectrum of presently accepted candidates for heart transplantation, end-stage heart failure in dilated cardiomyopathy has become the principle indication. Although several indicators of poor prognosis have been specified, the decision for heart transplantation is primarily made on clinical grounds. Expected long-term survival after transplantation is 60 to 80% at one year and more than 50% at five years. Since July, 1983, 50 patients underwent orthotopic heart transplantation, 38 of whom had been suffering from dilated cardiomyopathy. Ages ranged from nine to 54 years with a mean of 40 years. At present, 38 patients are alive, 34 are discharged from hospital, 14 have returned to work or school. Physical capacity and cardiac function are normal. There was no difference between the cardiomyopathy patients and the coronary artery disease patients with respect to rate and severity of rejection episodes, infection and long-term findings. Heart transplantation is considered a promising routine treatment for end-stage heart failure in particular in younger patients with dilated cardiomyopathy.

Adolescent↗

Perfluorochemicals as a treatment of decompression sickness in rats.

Perfluorodecalin and perfluorotripropylamine which have N2 solubility coefficients of 28.4 and 35.7 ml/dl, respectively, were used for treatment of decompression sickness in this study. Rats with chronically implanted venous catheters were held for 30 min at 800 kPa (7 bar, 8 ATA) by introducing compressed air into a chamber in which they were kept; a relatively short period of decompression followed (200 kPa/min). Immediately thereafter injections of the perfluorochemicals (PFCs) in a dose of 10 g/kg were given, controls received saline in the same volume or remained without treatment. An observation period of 2 h followed; after this time the incidence of death amongst the experimental animals (as compared with controls tested by the chi 2-test) showed that PFC treatment increased the likelihood of survival. Probit-log time relationship for the incidence of death also revealed a significant decrease in lethality in treated rats 30 min after the end of decompression. The mean lethal times Lt50 differed significantly, too. A still greater effect might be expected if the PFC emulsion were deprived of its normal nitrogen content by oxygenation before administration. Under the conditions of the present experiments PFCs produced an improvement in N2 exhalation at least in terms of the survival rate after compression followed by a very short decompression time.

Animals↗